In clinical studies, LithoLexal® demonstrated it helped users to reduce the use of traditional NSAIDs such as Ibuprofen. LithoLexal® has demonstrated an ability to reduce the impact of specific pro-inflammatory factors that lead to joint pain (COX-2).